In particular, patients with type 1 diabetes mellitus require insulin replacement therapy for life support and the regeneration of insulin-producing β-cells destroyed by autoantibodies and other factors for radical treatment [5]. The gene discussed is INS; the disease is type 1 diabetes mellitus.